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Introduction
Poly(ADP-ribose) polymerase-1 (PARP-1), the most abundant isoform of PARP family, is a highly conserved nuclear enzyme. It is a zincdependent DNA damage sensor that binds to both single-and double stranded DNA breaks [1, 2] facilitating both base excision repair and homologous recombination [3, 4] . When activated, PARP-1 covalently attaches PAR units deriving from NAD + to various nuclear proteins including itself, histones and other nuclear proteins such as transcription factors [5] [6] [7] . Oxidative stress or alkylating agents promote the formation of large amount of DNA breaks inducing the over-activation of PARP-1, which leads to inflammation, apoptotic and necrotic cell death [8] . In this process mitochondria play an important role [9, 10] since PARP-1 activation destabilizes mitochondria, collapses mitochondrial membrane potential, and induces cell death involving cytochrome Since mitogen activated protein kinases (MAPKs) are involved in a great variety of intracellular processes such as cell death, proliferation, differentiation and oncogenesis, the regulatory role of MAPK phosphatases (MKPs)/dual-specificity phosphatases (Dusps) are very complex [28, 29] . MAPKs are negatively regulated by MKP-1, therefore, activation of MKP-1 expression can play an important role in oxidative stressmediated damages. MKP-1 reduces oxidative stress-induced JNK and p38 MAPK activation, which are involved in mitochondrial damages and activation of cell death [16, 18] . Previously, we reported that PARP-1 inhibition in oxidative stress increased expression of MKP-1 at both the mRNA and protein levels [30] . Additionally, we found that PARP-1 inhibition/suppression failed to protect MKP-1-silenced cells [30] against the oxidative stress induced damages. Based on these findings, we proposed an MKP-1 mediated mechanism for the regulation of cytoplasmic MAPKs by nuclear PARP-1. However, the connection between PARP-1 activation and MKP-1 suppression has yet to be elucidated. Heat stress and heat shock factors (HSFs) were reported to play regulatory role in MKP-1 expression [31, 32] . In addition, since MKP-1 is a cAMP response element binding (CREB) protein-responsive gene, it can be regulated by CREB transcription factors [33, 34] .
Therefore, in the present study, we analyzed the role of HSF and CREB family transcription factors in oxidative stress induced MKP-1 suppression, identified the main transcription factor responsible for it, and provided experimental evidences for the existence and relevance of the retrograde pathway, via which PARP-1 activation malevolently affects MAPK signaling, mitochondrial integrity, reactive oxygen species (ROS) production, and viability.
Materials and methods

Cell culture
Human WRL-68 cells, a useful model for studying hepatocyte functions in vitro [35] , human A-549 lung cancer cells and human T24/83 bladder urothelial carcinoma cells were obtained from the ATCC (Wesel, Germany). The cells were grown in Eagle's minimum essential medium containing a 1% antibiotic-antimycotic solution and 10% fetal calf serum (FCS) in a humid 5% CO 2 atmosphere at 37°C.
RNA interference
A small interfering RNA (siRNA) method was used to knockdown HSF-1, HSF-2, HSF-4, Akt 1/2, PARP-1, MKP-1, CREB1 and ATF4/ CREB2 according to the manufacturer (Santa Cruz Biotechnology) in Opti-MEM I reduced serum medium (Invitrogen) using Lipofectamine 2000. For the effective suppression of HSF-1, PARP-1 and ATF4/CREB2 the transfection step was repeated 24-h after, and the experiments were performed on the cells 24 h after the second round of transfection.
Pharmacological inhibition of PARP and Akt
The PARP inhibitor PJ-34 [N-(6-Oxo-5,6-dihidro-phenanthridin-2yl)-N,N-dimethylacetamide] was purchased from Sigma, and was used at 10 μM concentration. The dose of PJ-34 was based on in vitro studies where the 10 μM PJ-34 concentration was proven to be the most effective [30] .
Cell viability assay
Viability of the WRL-68 cells was determined by colorimetric MTT assay (3-(4,5-dimethylthiazol-2-yl)−2,5-diphenyl tetrazolium bromide, Sigma) as described previously [30] . The cells were seeded onto 96 plates at a density of 10 5 cells/well and cultured overnight before the experiment. After 24 h of treatment, the medium was removed and fresh MEM/FCS containing 0.5% of the water-soluble yellow mitochondrial dye MTT was added. The cells were then incubated for 3 h at 37°C in an atmosphere of 5% CO 2 . After 3 h incubation the medium was removed and the water-insoluble blue formazan dye formed stochiometrically from MTT was solubilized by acidic isopropanol (Sigma). Optical densities were determined by a plate-reader (Anthos Labtech 2010) at the wavelength of 550 nm, and the values were represented as arbitrary units. All experiments were run at least four parallels and repeated three times. The results are expressed as percentages of control values.
Western blotting
Protein extracts were resolved on 12% and 10% SDS-PAGE gels, transferred onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) and blocked in 5% skim milk as described previously [30] . The membranes were probed overnight at 4°C with antibodies recognizing the following antigens: MKP-1, phospho-ERK1/2, phospho-p38, phospho-JNK, CREB1, ATF4/CREB2, PAR, PARP-1, HSF-1, HSF-2, HSF-4, (Santa Cruz Biotechnology). Nitrocellulose membranes were washed before addition of goat anti-rabbit horseradish peroxidaseconjugated secondary antibody (1:3000 dilution, Bio-Rad). The protein bands were visualized with enhanced chemiluminescence labeling (ECL) using an ECL immunoblotting detection system (Amersham Biosciences). In second step nitrocellulose membranes were washed with Western Blot Stripping Buffer (Santa Cruz Biotechnology) as described by the manufacturer, and were probed with mouse monoclonal anti-actin antibody (Santa Cruz Biotechnology) and anti-mouse alkaline phosphatase conjugated secondary antibody (Sigma). The protein bands were visualized using 5-bromo-4-chloro-3-indolyl phosphate disodium salt (Sigma). The developed films were scanned and the pixel volumes of the bands were determined by using NIH's Image J software, with the values in ratios of intensity. Each experiment was repeated a minimum of three times.
Preparation of nuclear fractions
Cells cultured on a 10 cm dish were rinsed in phosphate buffered saline solution pH 7.4 (PBS) and scraped off the plate after lysis with 500 μl buffer A [10 mM 4-(2-hydroxyethyl)−1-piperazineethanesulfonic acid (HEPES), 1 mM dithiothreitol, and 10 mM KCl, 0.1 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride (PMSF, pH 7.6)] on ice for 10 min and vortexed for 10 s. Nuclei were pelleted by centrifugation at 12,000g for 20 s. The supernatants containing cytosolic proteins were collected. The pellet was resuspended in 60 μl buffer B (20 mM HEPES, 5 mM EDTA, 0.4 M NaCl, 0.5 mM PMSF, 1% phosphatase inhibitor cocktail, 25% glycerol, pH 7.6) on ice for 30 min and then centrifuged at 12,000g for 20 min. The obtained supernatants were collected as nuclear fraction for further immunoprecipitation and DNA affinity protein binding studies.
Immunoprecipitation
500 μg nuclear extracts were immunoprecipitated by adding anti-ATF4 antibody and incubated overnight at 4°C, under agitation. Then 100 μl protein A-Sepharose (Sigma) was added to each nuclear extracts to absorb the antigen-antibody complex. Lysate-beads mixtures were incubated at 4°C under rotary agitation for 4 h. The beads were washed five times with 500 μl washing buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 1% nonyl phenoxypolyethoxylethanol and 10% glycerol). 25 μl 2x loading buffer were added into each samples, then boiled at 95-100°C for 5 min. Samples were centrifuged and the pure supernatants were used for immunoblotting detection of ADP-ribosylation.
DNA affinity protein-binding assay (DAPA)
The biotin-labeled oligonucleotides containing the consensus CRE site were synthesized based on the human CRE promoter sequence by Microsynth and annealed. The wild-type sequences were 5′-AGAGATTGCCTGACGTCAGAGAGCTAG-3′. The mutant sequences were 5′-AGAGATTGCCTGTGGTCAGAGAGCTAG-3′ [14] . Biotin-labeled double stranded oligonucleotides (2 μg) were mixed at room temperature for 1 h with shaking with 200 μg nuclear extract proteins, and 20 μl streptavidin magnetic beads in a 70% slurry. Beads were pelleted and washed with cold PBS three times. The bound proteins were separated by SDS-PAG electrophoresis, followed by Western blot analysis.
Chromatin immunoprecipitation -qPCR
ChIP was performed using Pierce Magnetic ChIP Kit according to the manufacturer's protocol with minor modifications. Briefly, 5×10 6 cells were treated with PJ-34 and/or H 2 O 2 for 3 h and then with 1% formaldehyde (Thermo Scientific) for 10 min. After crosslinking, chromatin was digested with micrococcal nuclease to generate 200-1000-bp fragments. Extracted chromatin was immunoprecipitated with antibodies against ATF4 (Abcam, ab85049), RNA polymerase II or with normal rabbit IgG. Chromatin-antibody complexes were precipitated with Protein A/G-coated magnetic beads. After six washing steps, complexes were eluted and reverse-crosslinked. DNA fragments were column purified. The amount of immunoprecipitated DNA was quantified by NanoDrop 2000. The EpiTect ChIP qPCR Assays were performed according to the manufacturer's protocol (GPH1024529(-)01 A, Qiagen) selected primers framed the assay position Chr5:172771903 on GRCh38 build. In the WRL68 cell line, we also evaluated enrichment of immunprecipitated DNAs regarding two additional, putative ATF4 binding sites based on the data of the ENCSR669LCD ATF4 ChipSeq experiment of ENCODE project in ± 150 nt ranges at assay positions of GRCh38 Chr5:172771150 and Chr5: 172772550. Applied primer sequences for Chr5:172771150: 5′-CTCTGCGCCGAACCAAAAG-3′ (FWD) and 5′-GCCGCATATAAACGCGCTC-3′ (REV); Chr5: 172772550, 5′-GGAACATTCTGCGGTTTCCTC-3′ (FWD) and 5′-GATACAGCTCGCACAGCGAC-3′ (REV). Five microliters of immunoprecipitated DNA template was used for real-time PCR detection. Real-time PCR runs were performed on a CFX96 Touch™ Real-Time PCR Detection System (Bio Rad) using 1 cycle of 95°C for 10, 40 cycles of 95°C for 15 s, and 60°C for 1 min, supplemented with melting curve (65-95°C, for 5 s/0,05°C) using pre-designed gapdh primers (ChIP positive control by Thermo Scientific) and pre-designed dusp-1 promoter-specific primers (for the following sequence: 5′-CGGTGACGTCA-3′, EpiTect ChIP qPCR Assay, Qiagen) and Maxima SYBR Green qPCR Master Mix (Thermo Scientific). Excel based ChIP qPCR data analysis (ddCt method; SABiosciences) was applied according to the manufacturer's recommendation.
Annexin V and propidium iodide staining of the cells
Cell death was quantitatively detected using flow cytometry. The ratio of apoptosis was evaluated after double staining with fluorescein isothiocyanate (FITC)-labeled annexin V (BD Biosciences) and propidium iodide (PI, BD Biosciences) using flow cytometry. The cells were washed twice with isotonic NaCl solution, then were removed from the plates using a mixture of 0.25% trypsin (Sigma), 0.2% EDTA, 0.296% sodium citrate and 0.6% sodium chloride in distilled water. This medium was applied for 15 min at 37°C. The removed cells were washed twice in cold PBS before being re-suspended in a binding buffer containing 10 mM HEPES, pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 . The cell-count was determined in Burker's chamber for achieving a dilution of 100 cells/ml. 100 μl of buffer containing 10 5 cells was transferred into 5 ml round-bottomed polystyrene tubes. The cells were incubated for 15 min with FITC-conjugated annexin V molecules and PI. After incubation 400 μl of annexin-binding buffer (BD Biosciences) was added to the tubes as described by the manufacturers. The samples were immediately measured using a BD FacsCalibur flow cytometer (BD Biosciences). The results were analyzed by Cellquest software (BD Biosciences). Quadrant dot plot was introduced to identify living and necrotic cells and cells in early or late phases of apoptosis. Necrotic cells were identified as single PI-positive. Apoptotic cells were branded as annexin V-FITC-positive only, and cells in late apoptosis were recognized as double-positive for annexin V-FITC and PI. Cells in each category were expressed as a percentage of the total number of stained cells counted.
2.11. JC-1 assay for flow cytometry JC-1 [5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide] assay kit for flow cytometry (Invitrogen, Molecular Probes, Hungary) was used to detect mitochondrial depolarization in the cell lines. After the indicated treatment, the cells were incubated in the presence of 2 µM JC-1 for 5 min. PAR level was determined by anti-PAR monoclonal antibody followed by the labeling with green second antibody. MKP-1 levels were determined by anti-MKP-1 rabbit polyclonal antibody coupled with red second antibody. The cells were washed with PBS, then were immediately analyzed by a BD FacsCalibur flow cytometer (BD Biosciences, USA). Data were accumulated and reduced by Cellquest software (BD Biosciences, USA). JC-1 is accumulated in the mitochondria in a potential-dependent manner, indicated by a fluorescence emission shift from red (≈590 nm) to green (≈529 nm) upon depolarization. Consequently, mitochondrial depolarization is indicated by decrease in the red/green fluorescence intensity ratio. Cells were expressed as percentage of the total number of stained cells counted. All experiments were repeated three times.
JC-1 assay for fluorescence microscopy
Mitochondrial membrane depolarization was detected by using JC-1 dye (Sigma) at the final concentration of 1 μM. 2 μg/ml Hoechst stain (Invitrogen, Molecular Probes) was used to stain nucleus. WRL-68 cells were seeded on poly-L-lysine-coated (2.5-5 μg/cm2) glass coverslips and cultured at least overnight before experiments. After subjecting the cells to the appropriate treatment (as indicated in the figure legends), coverslips were rinsed twice in phosphate-buffered saline and cells were incubated in phosphate-buffer containing JC-1 (5 mg/ml) and Hoechst 33342 (1 mg/ml) stains for 30 min in a CO 2 incubator at 37°C. Then, coverslips were placed upside down on the top of a small chamber formed by a microscope slide and a press-to-seal silicone isolator. The chamber was filled with phosphate-buffered saline. Images were taken with a Nikon microscope (Inverted Microscope Eclipse Ti-U Instruction, Hungary) equipped with a SPOT RT3 2Mp Monochrome camera includes SPOT Basic software, using a 60x objective. The same microscopic field was first imaged using the red channel followed by the green and blue channels, and the resulting images were merged by Adobe Photoshop 7.0. In control experiments, we did not observe considerable bleed-through between the red and green channels. The same calibration parameters were applied for the batch of images obtained from one experiment. All experiments were performed in triplicate. provide the excitation light. The blue wavelength snap-in optical kit excites at 490 nm and has a detection range of 510-570 nm, or the green wavelength fluorescent kit excites at 525 nm and has a detection range of 580-640 nm. Using untreated cells as a reference, the intracellular ROS levels were calculated by the average of three measurements.
Measurement of intracellular reactive oxygen species (ROS) levels
For the fluorescence microscopy the pretreated cells were washed twice in Krebs -Henseleit buffer after the treatment with 2 µM DHR123. This is a reliable qualitative assay to demonstrate increase in mitochondrial ROS formation. The cells were visualized by Nikon Eclipse Ti-U fluorescent microscope equipped with a Spot RT3 camera using a 60x objective and epifluorescent illumination. For quantitative information, fluorescent intensity of nine randomly chosen fields of a 40x objective containing altogether at least 100 cells was determined after background correction by using NIH's ImageJ software. Untreated cells were utilized as a reference, and the experiments were repeated three times.
Statistical analysis
All data were expressed as mean ± standard error of mean (SEM), and were analyzed using the Kolmogorov-Smirnov normality test followed by one-way ANOVA and Bonferroni post hoc multiple comparison tests. Differences were considered significant at p < 0.05. Analyses were performed using IBM SPSS Statistics 20 software.
Results
Effect of oxidative stress and PARP inhibition on MKP-1 expression in different cell lines
Previously, we have demonstrated that PARP inhibition led to increased MKP-1 expression in WRL-68 cells [26] . To demonstrate possible universality of this phenomenon, we induced oxidative stress by exposing three human cell lines originated from different tissues, WRL-68, A-549 and T24/83-0.3 mM H 2 O 2 for 3 h in the presence and the absence of the PARP inhibitor PJ-34 [36] , and assessed MKP-1 expression in them by using flow cytometry utilizing anti-MKP-1 primary antibody. As we found, H 2 O 2 increased MKP-1 expression that was further increased by PARP inhibition in all three cell lines ( Fig. 1 ). Therefore, PARP-1 driven PARylation seems to suppress MKP-1 expression universally, however, the transcription factor involved in this effect has yet to be identified.
Effect of HSF silencing on PARP inhibitor-induced MKP-1 expression in oxidative stress
Heat shock factors reportedly can play a role in the regulation of MKP-1/Dusp1 expression in heat stress [32] . Therefore, we analyzed the possibility that HSF-1, −2 or −4 have similar role in oxidative stress. HSF-3 was not studied because it is mainly expressed in the avian [37] . WRL-68 cells transfected with plasmids expressing HSF-1, −2 or −4 siRNA were treated with 0.3 mM H 2 O 2 for 3 h in the presence and the absence of PJ-34. Expression of MKP-1 was analyzed by immunoblotting using a specific primary antibody. We found that HSF-1 suppression increased MKP-1 levels in all four treatment groups ( Fig. 2A ) while HSF-2 ( Fig. 2B ) or −4 ( Fig. 2C ) silencing did not affect PARP inhibitor-induced MKP-1 expression. All these data indicate that heat shock family transcription factors do not mediate PARP inhibitorinduced MKP-1 expression in oxidative stress.
Effect of CREB silencing on PARP inhibitor-induced MKP-1 expression in oxidative stress
It was previously demonstrated that cAMP responsive elements (CREs) can play a role in the regulation of MKP-1 under different conditions [38, 39] . Therefore, we analyzed the role of CREB1 and ATF4/CREB2 transcription factors in PARP inhibitor-induced MKP-1 expression under the conditions of oxidative stress, similarly as we did for the HSF family members. We found that CREB1 silencing did not decrease H 2 O 2 and PARP inhibition-induced MKP-1 expression ( Fig. 3A) .
On the other hand, silencing of ATF4/CREB2 transcription factor by siRNA caused markedly decreased MKP-1 protein levels in all four treatment groups (Fig. 3B ) indicating that ATF4/CREB2 transcription factor can mediate the effect of PARP-1 in the regulation of MKP-1 expression in oxidative stress (Fig. 3B ). 
Effect of ATF4/CREB2 suppression on MKP-1 expression in different cell lines
We intended to demonstrate that MKP-1 suppressive effect of PARP activation in oxidative stress is not a specific situation in WRL-68 cell lines only. Therefore, we performed the experiment described in the previous paragraph on human T24/83 bladder urothelial carcinoma ( Fig. 3C ) and A-549 human lung cancer (Fig. 3D ) cell lines. The results were very similar to those of WRL-68 cell line (Fig. 3B ). In both cell lines, the MKP-1 expression enhancing effect of the PARP inhibitor PJ- 34 in oxidative stress was abolished by ATF4 silencing (Fig. 3C, D) . It suggests that, possibly universally, PARP activation mediates its effect on MKP-1 via the regulatory transcription factor ATF4 in oxidative stress.
Effect of PARP-1 silencing on MKP-1 expression in wild type and ATF4/CREB2 suppressed cells
Specificity of synthetic inhibitors such as PJ-34 is always an issue. Therefore, we performed a PARP-1 specific, non-pharmacological inhibition of PARP-1 by siRNA silencing in WRL-68 cells. As it is demonstrated in Fig. 3E , suppression of PARP-1 protein by siRNA induced a significant activation of MKP-1 in oxidative stress similarly as it was observed for the pharmacological inhibitor PJ-34. Additionally, PARP-1 silencing-induced MKP-1 expression in oxidative stress was attenuated by ATF4/CREB2 suppression as it was observed in the case of PJ34 mediated PARP inhibition. These data together with those shown in Fig. 3B indicate that oxidative stress by itself is able to activate ATF4/CREB2 expression, which can be modulated by PARP-1 activation. Additionally, PARP inhibition in oxidative stress can affect ATF4-regulated processes, such as the MKP-1-MAPK pathway.
Effect of ATF4/CREB2 suppression on MAPK activation in oxidative stress
To determine the functional consequences of the aforementioned effects, we analyzed activation of the MAPKs under the conditions of oxidative stress, ATF4/CREB-2 suppression and PARP inhibition in WRL-68 cells by using phosphorylation specific primary antibodies and immunoblotting. Extracellular signal-regulated kinase (ERK) 1/2 phosphorylation level increased under oxidative stress that was augmented by the PARP inhibitor (Fig. 4A) . Silencing of the ATF4/CREB2 gene resulted in a much increased activation of ERK1/2 (Fig. 4A) presumably because of the decreased MKP-1 level. Furthermore and in contrast to the wild type cell line, PJ-34 failed to further increase the oxidative stress-induced ERK1/2 activation. Similarly to ERK1/2, the oxidative stress markedly increased p38 MAPK phosphorylation. However and unlike in the case of ERK1/2, the PARP inhibitor attenuated this activation (Fig. 4B ). ATF4/CREB2 suppression increased p38 MAPK activation in every treatment group while the p38 MAPK phosphorylation pattern was similar to that of the wild type cells (Fig. 4B ). Activation pattern of JNK1/2 was very similar to that of p38 MAPK both in the wild type and ATF4/CREB2 silenced cells (Fig. 4C ). All these results indicate that the regulatory effect of PARP inhibition on the MAPKs is impaired in the absence of ATF4/CREB2.
PARP-1 regulates ATF4/CREB2 binding to CRE elements regulating MKP-1
It is well-documented that PARP-1 is activated in oxidative stress. Therefore one of its possible effects on ATF4/CREB2 is poly-ADPribosylation, which may affect ATF4/CREB2 binding to CRE. To test this hypothesis, we isolated nuclei of H 2 O 2 and PJ-34 treated WRL-68 cells, extracted the nuclear proteins, immunoprecipitated ATF4/CREB2, and determined poly-ADP-ribosylation of ATF4/CREB2 by using anti-PAR antibody and immuno-blotting ( Fig. 5A ). We found that ATF4/ CREB2 was poly-ADP-ribosylated in oxidative stress that was significantly decreased by the PARP inhibitor (Fig. 5A ). As expected, PJ-34 diminished PARylation of ATF4/CREB2 in unstimulated cells too (Fig. 5A) .
To test whether the PARylation affects ATF4/CREB2's binding to the CRE consensus site, we performed a DNA affinity protein-binding assay. We extracted nuclear proteins of H 2 O 2 and PJ-34 treated cells with biotinylated-CRE and mutated-CRE sequences as bait, pulled-down the biotinylated-DNA-protein aggregates with streptavidine beads, and analyzed their protein content by using anti-ATF4/CREB2 primary antibody and immuno-blotting. We found that the mutated CRE sequence did not bind detectable amount of ATF4/CREB2 in any of the treatment groups. In contrast, a massive ATF4/CREB2 binding to the CRE sequence could be observed in the untreated cells that was not affected by PJ-34, but was significantly reduced by the H 2 O 2 treatment (Fig. 5B ). Furthermore, this oxidative stress-induced decrease of ATF4/ CREB2-CRE binding was significantly prevented by the PARP inhibitor (Fig. 5B) . These results together with those on ATF4/CREB2 PARylation indicate that our aforementioned hypothesis was correct.
Additionally, we analyzed PARP-1 binding to CRE sequences using the same experimental set-up as we used for ATF4/CREB2 binding. A strong binding of PARP-1 to the CRE sequence was present even in unstimulated cells that were significantly reduced by the PARP inhibitor PJ-34. Oxidative stress robustly augmented PARP-1 binding to CRE that was again reduced by PJ-34 (Fig. 5B ). Since PARP-1 did not bind to the mutated CRE sequence in any of the treatment groups (Fig. 5B) , this binding of PARP-1 seems to be site specific. These data show that catalytically active PARP-1 binds preferentially to CRE sequences and acts there as a suppressor of ATF4/CREB2 by PARylating it thereby decreasing its binding to the CRE site.
Chromatin immuno-precipitation followed by qPCR analysis by commercial primers (GPH1024529(-)01 A, Qiagen) -Chr5:172771903-showed that the PARP inhibitor increased the ATF4/CREB2 enrichment at the initiation site of MKP-1 (Fig. 5C ), supporting our hypothesis that ATF4/CREB2 mediates the effect of PARP inhibition on MKP-1 expression. For exploring additional, putative ATF4/CREB2 binding sites, we inspected the mapping data from the ENCSR669LCD ATF4 ChipSeq experiment of ENCODE project in the promoter region of MKP-1 gene. It delineated two major peaks of potential ATF4/CREB2 binding sites Chr5:172771150 and Chr5: 172772550 (Fig. 5C ). PCR analysis for the enrichment of ATF4 antibody immunoprecipitated sequenses indicated an oxidative stress related increased occupancy of ATF4/ CREB2 in all studied regions. While PJ-34 treatment alone induced a profound enrichment in Chr5:172771150 region, this effect was comparably lower on Chr5: 172772550 and Chr5: 172771903 regions (Fig. 5C ), though still reinforced PARP-1 activity related regulation of these binding sites. PJ-34 pre-treatment of H 2 O 2 stressed WRL68 cells significantly increased enrichment of ATF4 immunoprecipitated DNA sequences in both regions compared to all study groups (Fig. 5C ).
Effect of ATF4/CREB2 suppression on mitochondrial membrane potential in oxidative stress
It is well documented that PARP inhibitors protect against oxidative stress-induced cell death and can prevent the oxidative stress-induced depolarization of mitochondrial membrane potential [22, 40] . Accordingly, we found that 10 µM PJ-34 protected the mitochondria against oxidative stress-induced depolarization in WRL-68 cells as it was demonstrated by JC-1 staining and fluorescent microscopy (Fig. 6A) . The membrane potential dependent fluorescent dye, JC-1 accumulates in healthy mitochondria and forms red fluorescent aggregates. Upon depolarization, the aggregates disassemble, lose their red fluorescence, and green fluorescence of the JC-1 monomers becomes dominant. As it is demonstrated in Fig. 6A , suppression of MKP-1 diminished the protective effect of the PARP inhibitor indicating the important role of the MAPKs in causing mitochondrial damage. Silencing of ATF4/ CREB2 transcription factor that was found to mediate MKP-1 induction by the PARP inhibitor also reduced the protective effect of PARP inhibitor on oxidative stress-induced mitochondrial membrane potential collapse (Fig. 6A) . Quantitative data were also obtained by repeating the aforementioned experiment on all three cell lines but using flow cytometry instead fluorescent microscopy ( Fig. 6B-D) . Identically to the results in Fig. 6A , we found that either MKP-1 or AFT4/CREB2 suppression significantly reduced the protective effect of the PARP-inhibitor ( Fig. 6B-D) in all three studied cell line. These data indicate functionality of the PARP inhibition -ATF4/CREB2 activation -MKP-1 expression retrograde pathway in protecting the mitochondrial membrane system.
Role of ATF4/CREB2 in the PARP inhibitor suppressed mitochondrial ROS production
Mitochondrial ROS production can be responsible for apoptotic, necrotic and necroptotic cell death [41] . The regulation of mitochondrial ROS production can be critical in cell survival. Therefore, we assessed mitochondrial ROS production by subjecting WRL-68 cells to the same treatment protocol as in the previous experiments, and loaded them with non-fluorescent dihydrorhodamine123 dye, which predominantly detect peroxynitrite. We visualized the green fluorescence of Rhodamine123 oxidized by the mitochondrial ROS from dihydrorho-damine123 by fluorescent microscopy (Fig. 7A ) and quantified the fluorescent intensity of randomly chosen microscopic fields (Fig. 7A ). As we found, PARP inhibition significantly reduced mitochondrial ROS production that was attenuated by ATF-4 silencing (Fig. 7) .
ROS productions were detected in 96 well plate using dihydrorho-damine123 (Fig. 7B) , dihydrofluorescein diacetate (Fig. 7C) [42] and MitoSOX in the presence and the absence of MitoTEMPO (Fig. 7D ) [43, 44] . All of these data show that PARP inhibition reduces hydrogen peroxide-induced ROS production using the different ROS specific dyes in normal cells. Additionally, the MitoTEMPO experiment (Fig. 7D) indicates that majority of the ROS formation was localized to the mitochondria. However, ATF4 suppressed cells PARP inhibition failed to reduce ROS production ( Fig. 7B-D) showing that PARP inhibition executes this effect through ATF4. Fig. 5 . Effect of PARP inhibition on ATF4/CREB2's PARylation and binding to the MKP-1/Dusp1 promoter region. WRL-68 cells were treated or not with 0.3 mM H 2 O 2 with or without PJ-34 for 30 min. PARylation of ATF4/CREB2 (A) was detected from nuclear extract of the cells by Western blotting following immunoprecipitation utilizing ATF4/CREB2 specific primary antibody. From separate aliquots of nuclear extracts, DNA affinity protein binding assay was performed using consensus and mutated ATF4/CREB2-CRE site as bait and Western-blotting for detecting ATF4/CREB2 and PARP-1 (B). ChIP-qPCR analysis was performed to measure the capacity of ATF4 binding to MKP-1 Dusp1 promoter region position 1 (Chr5: 172771150+/−150 nt), 2 (Chr5:172772550+/−150 nt), 3 (Chr5:172771903). MKP-1 Dusp1 promoter region positions derived from the graphical view of ATF4 ChIP-seq binding peaks (tag densities). (C). Data of three parallel experiments are presented as representative blots and bar diagrams of means ± SEM. * p < 0.05 between H 2 O 2 and H 2 O 2 + PJ-34 groups; † p < 0.05 compared to the untreated control group; a.u. arbitrary units. The above data indicated the high importance of MKP-1 and ATF4/ CREB2 expression in the protective effects of PARP inhibition in oxidative stress. Therefore, we determined the effect of MKP-1 and ATF4/CREB2 suppression on H 2 O 2 -induced cell death in all three cell lines (WRL-68, T24/83 (Human bladder carcinoma) and A549 (Human lung carcinoma)) in the presence of PJ-34. As previously [30] , we found that the PARP inhibitor had significant protection against cell death (Fig. 8 ). Silencing of MKP-1 almost completely diminished the protective effect of PJ-34 ( Fig. 8 ) that is in accord with the results on mitochondrial damages (Fig. 6 ) and MAP kinase activation (Fig. 4) . Similarly, suppression of ATF4/CREB2 made the PARP inhibitor ineffective against the oxidative stress-induced cell death (Fig. 8) . Again, these data were in line with those on the protection of the mitochondrial membrane system and suppression of MAPK activation. Additionally, the uniformity of the results among the three studied cell lines suggests a potential universality of the role of the PARP-1-A-TF4-MKP-1-MAPK pathway in mediating oxidative damage.
Discussion
A number of reports indicate extranuclear effects of PARP activation that are not associated with excess consumption of the substrate NAD and consequent energy depletion. [11, 12] . In oxidative stress-or alkylating agents-induced PARP activation, collapse of mitochondrial membrane potential, mitochondrial permeability transition, even cell death can occur [11, 12, 18, 20] , and these effects are frequently mediated by the activation of JNK and p38 MAP kinase pathways [18, 20, 45] . Additionally, it was demonstrated that oxidative stressinduced cell death can be reduced by activating MKP-1 [46] , which can inactivate JNK1. Besides JNK1, MKP-1 dephosphorylates thereby inactivates ERK1/2, JNK2 and p38 MAP kinases, therefore, any mechanism that activates MKP-1 can be protective in PARP activation-induced mitochondria-related cell death. In a previous study, we demonstrated that inhibition, or silencing of PARP-1 activated MKP-1 expression, and increased its concentration both in nuclear and cytoplasmic compartments [30] . We also showed that PARP inhibition inactivated JNK and p38 MAP kinases, protected mitochondrial membrane potential and reduced PARP activation mediated cell death [30] . However, the nuclear target of PARP-1, via which it can regulate MKP-1 expression is yet to be identified.
According to previous reports, MKP-1 expression can be regulated by heat shock, or by CRE-related mechanism, therefore, we investigated HSF and CREB transcription factors as potential targets of PARP-1 (27, 28, 32) . As we found, suppression of HSF-1, −2, −4 or CREB1 did not eliminate the PARP inhibition-induced MKP-1 expression indicating that PARP inhibition/activation regulation of MKP-1 expression was not mediated by heat shock factors or CREB1. In contrast, silencing of ATF4/CREB2 significantly reduced the PARP inhibition-induced MKP-1 expression in oxidative stress suggesting that this transcription factor could be the target of PARP-1 we were looking for. For the aforementioned experiments, we used PJ-34, a synthetic PARP inhibitor. However, specificity of pharmacological inhibitors is always an issue. Although PJ-34 effectively reduced PARylation and activated MKP-1 expression as we demonstrated in Fig. 1 and previously [30] , we had to prove that our observations are due to its PARP inhibitory property, and not resulted from an unexpected side effect of it [47] . Silencing of PARP-1 by siRNA reduced PARP-1 levels by about 80%, and activated MKP-1 expression similarly to PJ-34. Furthermore, ATF4/CREB2 silencing by siRNA eliminated the PARP-1 suppression-induced MKP-1 expression the same way as PJ-34 did indicating that the enzymatic activity of PARP-1 was the important factor in regulating MKP-1 expression.
Indeed, the oxidative stress-induced PARP-1 activation resulted in a massive poly-ADP-ribosylation of ATF4/CREB2. Furthermore, the PARylated ATF4/CREB2 showed reduced affinity toward its target DNA sequence as we revealed by DNA affinity protein-binding assay. PJ-34 eliminated the oxidative stress-induced poly-ADP-ribosylation of ATF4/CREB2, and restored its binding to CRE. PARP-1 also bound to the CRE sequence selectively that was augmented by oxidative stress and diminished by inhibition. Additionally, neither ATF4/CREB2 nor PARP-1 bound to a mutated CRE sequence in any of the treatment groups indicating the specificity of the DNA binding. Mapping data from the ENCSR669LCD ATF4 ChipSeq experiment of ENCODE project delineated three putative ATF4/CREB2 binding sites in the promoter region of MKP-1 gene; Chr5:172771903, Chr5:172771150 and Chr5: 172772550 (Fig. 5C ). Chromatin immuno-precipitation analysis demonstrated that oxidative stress or the PARP inhibitor, separately, increased the ATF4/CREB2 enrichment in all these regions. However, the PARP inhibition and oxidative stress further augmented binding of ATF4/CREB2 to all three aforementioned sites (Fig. 5C ) indicating that ATF4/CREB2 mediated the effect of PARP inhibition on MKP-1 expression. All these data suggest the following mechanism. Upon oxidative stress, DNA breaks activate PARP-1 that poly-ADP-ribosylates ATF4/ CREB2 transcription factor. When PARylated, the transcription factor fails to bind to its responsive elements, and is replaced to self-PARylated PARP-1 resulting in diminished expression of MKP-1 that leads to increased activation of MAPKs, which cause mitochondrial damage and necrotic or apoptotic cell death. Accordingly, PARP inhibition prevents CREB2 PARylation thereby restoring its CRE binding. It leads to increased MKP-1 expression that reduces MAPK activation eventually resulting in mitochondrial protection and cell survival.
Completely in agreement with this model, our previous [30] and present data show that PARP-1 inhibition-or suppression-induced activation of MKP-1 expression was always accompanied by a decreased phosphorylation of the MAPKs (Fig. 4 ). Furthermore, as we found, the PARP inhibitor failed to exert this aforementioned effect in ATF4/CREB2 silenced cells (Fig. 3) indicating the importance of this transcription factor in mediating this effect. A number of reports demonstrate the crucial role of JNK1/2 and p38 MAPK in mediating the mitochondrial damages upon PARP activation in oxidative stress [18, 48] and the protective effect of PARP inhibitors against these damages [12, 22, 49] . Completely in line with our proposed model, PJ-34 failed to protect the mitochondrial membrane systems against oxidative stress-induced depolarization in ATF4/CREB2 silenced cells ( Fig. 6 ). Analyzing cell death provided further supporting information, namely, the PARP inhibitor-induced protection vanished in ATF4/ CREB2 and MKP-1 suppressed cells (Fig. 8) .
Significance of PARP inhibition in oxidative stress-related diseases initially was restricted to prevention of NAD + -and ATP-depletion [50, 51] . We were among the first who suggested that PARP activation in inflammation and oxidative stress cause mitochondrial damagerelated cell death [22, 23] that was followed by establishing the role of JNK and p38 MAP kinase activation in this process by others [17, 18, 45] . Here, we present a completed PARP-1 mediated retrograde signaling pathway for the oxidative stress-related cell death process (Fig. 8C ). This PARP-1 inhibition -ATF4/CREB2 activation -MKP-1 expression -JNK-and p38 MAPK-inactivationmitochondrial damage preventioncytoprotection pathway could be an important mechanism in oxidative stress-related diseases. Furthermore, this pathway could represent a novel mechanism contributing to the beneficial effects of PARP inhibitors in cancer therapy. Since JNK activation was reported to be involved in to the development of cancer stem cell formation, JNK inhibition can be sufficient to induce the loss of the tumor-initiating capacity of cancer stem cells [52, 53] . Therefore, PARP inhibitors can suppress the tumor-initiating capacity of cancer stem cells by the aforementioned mechanism. It is conceivable that this mechanism significantly contributes to the therapeutic efficacy and long progression-free survival providing capacity of PARP inhibitors observed in recent phase II clinical studies for different tumor types [54] [55] [56] [57] .
In conclusion, PARP inhibition or suppression activates ATF4/ CREB2 binding to CRE sequences and stimulates MKP-1 expression, while oxidative stress-induced activation of PARP-1 results in poly-ADP-ribosylation of ATF4, its diminished binding to CRE sequences leading to reduced MKP-1 expression. MKP-1 inactivates MAP kinases, prominently JNK and p38 MAPK, that plays important role in oxidative stress-induced mitochondrial damage. By reducing MAPK activity, PARP inhibition reduces mitochondrial ROS production, protects mitochondrial integrity and attenuates cell death on three different human cell lines. Therefore, this pathway can be significant in cytoprotection in oxidative stress related diseases. In addition, since JNK plays significant role in the tumor-initiating capacity of cancer stem cells, the PARP inhibitor -ATF activation -MKP-1 expression -JNK inactivation retrograde pathway can play important role in cancer therapy.
